On Tuesday, November 5, the Federal Circuit voted 6-4 to deny a request for en banc rehearing in Fresenius vs. Baxter. The court decision in July held that “cancellation of a patent on re-examination can wipe out an infringement judgment.” Finnegan partner James R. Barney told Law360 “The en banc court split dramatically and the dissent uses language flagging this as an important constitutional issue,” he said. “It has all the ingredients to have as a good a chance as any of being taken up by the Supreme Court.”
Barney also said, “What makes this case stand out is the degree to which the district court decision is perceived to be final,” where even a final court decision that the patent is valid and infringed is not final enough. He noted interesting implications in light of new America Invents Act proceedings, adding, “This is a very important case for the bar because of the new post-grant review procedures that are in place and that new emphasis by Congress and the PTO on using those procedures. Patent litigation is high stakes and litigants look for any opportunity to press their advantage.”
Press Release
October 6, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say
September 17, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.